LC 1

Drug Profile

LC 1

Alternative Names: Dimethylamino-parthenolide; LC-1

Latest Information Update: 01 May 2012

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Leuchemix
  • Class Antineoplastics; Sesquiterpenes; Small molecules
  • Mechanism of Action Apoptosis stimulants; NF-kappa B inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Suspended Acute myeloid leukaemia

Most Recent Events

  • 31 Dec 2009 Suspended - Phase-I for Acute myeloid leukaemia in United Kingdom (PO)
  • 28 Jan 2009 Phase I clinical trials in Acute myeloid leukaemia in United Kingdom (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top